Catherine Sullivan

Consultant Rheumatologist

Dr Catherine Sullivan graduated from UCD in 2001 with honours and went on the complete higher specialist training in rheumatology and internal medicine.

During her training, she was awarded a PhD by NUI Galway for several years of laboratory research carried out in Galway and Harvard University Boston. The results of this novel research into the role of mesenchymal stem cells in murine models of inflammatory arthritis were published in peer-reviewed journals.

Dr Sullivan was appointed as a permanent consultant in Galway University Hospital in 2013 but relocated back to Dublin in 2017 for family reasons. During her time in Galway, she was the clinical lead for a European study of stem cells in knee OA in collaboration with the Regenerative Medicine Institute in GUH.

She has a wide range of experience in the management and treatment of all rheumatological disorders and a special interest in inflammatory arthritis and in particular the spondyloarthropathies.

Certificate in Healthcare Management (University College Dublin) – 2011, Medal Winner Mater Hospital / Smurfit Business School Business Proposal 2012

Ph.D. (NUI Galway)

Mesenchymal Stem Cells and Gene Therapy in Inflammatory Arthritis – June 2010.

Member of the Royal College of Physicians of Ireland – November 2003.

United States Medical Licensing Examinations – 2002

MB BCh BAO (Hons.), National University of Ireland, Dublin – May 2001

The Preferential Homing of Mesenchymal Stem Sells to Sites of Inflammation. Sullivan C.
Book Chapter: The Biology and Therapeutic Application of Mesenchymal Cells. Edited by Kerry Atkinson. Published by Wiley-Blackwell November 2016

Cardiovascular Risk Factors in an Ankylosing Spondylitis Cohort
Fitzgerald G, Lundon DJ, Gallagher P, Sheehy C, Sullivan C, Silke C, Stafford F, O Rourke K, Haroon M, Mullan R, FitzGerald O, O’Shea F. High Prevalence of Traditional
Arthritis Rheumatol. 2015; 67 (suppl 10).

TNFalpha and IL-1beta influence the differentiation and migration of murine MSCs independently of the NF-kappaB pathway.
Sullivan CB, Porter RM, Evans CH, Ritter T, Shaw G, Barry F, Murphy JM.
Stem Cell Res Ther. 2014 Aug 27;5(4):104.

The use of anti-TNF therapy for ankylosing spondylitis in everyday rheumatology practice and the relationship to disease activity, work disability and diagnostic delay.
Sullivan C, Quinn K, Harney S, Ryan JG. Ir J Med Sci. 2013 Dec 21

Allogeneic murine mesenchymal stem cells: migration to inflamed joints in vivo and amelioration of collagen-induced arthritis when transduced to express CTLA4Ig.
Sullivan C, Barry F, Ritter T, O’Flatharta C, Howard L, Shaw G, Anegon I, Murphy M.
Stem Cells Dev. 2013 Dec 15;22(24):3203-13.

Contact Catherine Sullivan
Suite: 12
Secretary: Mel Antal